Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice

Renal fibrosis is considered to be the final common outcome of chronic kidney disease. Dipeptidyl peptidase-4 (DPP-4) inhibitors have demonstrated protective effects against diabetic kidney disease. However, the anti-fibrotic effect of evogliptin, a DPP-4 inhibitor, has not been studied. Here, we re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi-Jin, Kim, Na-young, Jung, Yun-A, Lee, Seunghyeong, Jung, Gwon-Soo, Kim, Jung-Guk, Lee, In-Kyu, Lee, Sungwoo, Choi, Yeon-Kyung, Park, Keun-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043988/
https://www.ncbi.nlm.nih.gov/pubmed/31701692
http://dx.doi.org/10.4093/dmj.2018.0271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043988/
https://www.ncbi.nlm.nih.gov/pubmed/31701692
http://dx.doi.org/10.4093/dmj.2018.0271

Ejemplares similares